Oral bioadhesive drug delivery systems

Drug Development and Industrial Pharmacy

Volumn 31, Issue 3, 2005, Pages 293-310

  Bruschi, Marcos Luciano ^a,b   De Freitas, Osvaldo ^b  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Bioadhesion; Buccal; Drug delivery systems; Oral cavity; Oral mucosa

Indexed keywords

BENZOIC ACID; BUPRENORPHINE; CARBOPOL 934; CARBOXYMETHYLCELLULOSE; CETYLPYRIDINIUM SALT; DILTIAZEM; DODECYL SULFATE SODIUM; ERGOTAMINE; GLYCERYL TRINITRATE; HYDROXYPROPYLMETHYLCELLULOSE; LEUCINE ENKEPHALIN; LIDOCAINE; MACROGOL; MAGNESIUM STEARATE; METHACRYLIC ACID METHYL ESTER; METHYLCELLULOSE; METOPROLOL TARTRATE; MICONAZOLE; MICONAZOLE NITRATE; NICOTINE GUM; NIFEDIPINE; OMEPRAZOLE; PENTAZOCINE; PLASMID DNA; POLYCARBOPHIL; POLYETHYLENE; POLYMER; SILICON DIOXIDE; TESTOSTERONE; UNINDEXED DRUG;

CHEWABLE TABLET; CHEWING GUM; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG ELIMINATION; DRUG TRANSPORT; FILM; FIRST PASS EFFECT; GASTROINTESTINAL TRACT; GEL; HUMAN; LOZENGE; MOUTH CAVITY; MOUTH MUCOSA; NONHUMAN; REVIEW; SUSTAINED DRUG RELEASE; TABLET; TRANSDERMAL PATCH; VASCULARIZATION;

ANIMALS; BIOLOGICAL AVAILABILITY; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH MUCOSA; TABLETS;

EID: 16244377780     PISSN: 03639045     EISSN: None     Source Type: Journal    
DOI: 10.1081/DDC-52073     Document Type: Review

References (99)

1. Agarwal, V., & Mishra, B. (1999). Design, development, and biopharmaceutical properties of buccoadhesive compacts of pentazocine. Drug Development and Industrial Pharmacy, 25(6), 701-709.
2. Ahuja, A., Khar, R. K., & Ali, J. (1997). Mucoadhesive drug delivery systems. Drug Development and Industrial Pharmacy, 23(5), 489-515.
3. Ali, J., Khar, R., Ahuja, A., & Kaltra, R. (2002). Buccoadhesive erodible disk for treatment of orodental infections: design and characterization. International Journal of Pharmaceutics, 283, 93-103.
4. Alur, H. H., Indiran Pather, S., Mitra, A. K., & Johnston, T. P. (1999a). Transmucosal sustained-delivery of chlorpheniramine maleate in rabbits using a novel, natural mucoadhesive gum as an excipient in buccal tablets. International Journal of Pharmaceutics, 188, 1-10.
5. Alur, H. H., Beal, J. D., Indiran Pather, S., Mitra, A. K., & Johnston, T. P. (1999b). Evaluation of a novel, natural oligosaccharide gum as a sustained-release and mucoadhesive component of calcitonin buccal tablets. Journal of Pharmaceutical Sciences, 88(12), 1313-1319.
6. Ameye, D., Voorspoels, J., Foreman, P., Tsai, J., Richardson, P., Geresh, S., & Remon, J. P. (2002). Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic acid) copolymers and starch/poly(acrylic acid) mixtures. Journal of Controlled Release, 79, 173-182.
7. Anders, R., & Merkle, H. P. (1989). Evaluation of laminated mucoadhesive patches for buccal drug delivery. International Journal of Pharmaceutics, 49, 231-240.
8. Artusi, M., Santi, P., Colombo, P., & Junginger, H. E. (2003). Buccal delivery of thiocolchicoside: in vitro and in vivo permeation studies. International Journal of Pharmaceutics, 250, 203-213.
9. Aungst, B. J., & Rogers, N. J. (1988). Site dependence of absorption-promoting actions of laureth-9, Na salicylate, and aprotinin on rectal, nasal, and buccal insulin delivery. Pharmaceutical Research, 5, 305-308.
10. Beyssac, E., Touaref, F., Meyer, M., Jacob, L., Sandouk, P., & Aiache, J.-M. (1998). Bioavailability of morphine after administration of a new bioadesive buccal tablet. Biopharmaceutics and Drug Disposition, 19, 401-405.
11. Bottenberg, P., Cleymaet, R., Röhrkasten, K., & Lampert, F. (2000). Microhardness changes in surface enamel after application of bioadhesive fluoride tablets in situ. Clinical Oral Investigations, 4, 153-156.
12. Bouckaert, S., & Remon, J. P. (1993). In-vitro bioadhesion of a buccal, miconazole slow-release tablet. Journal of Pharmacy and Pharmacology, 45, 504-507.
13. Bouckaert, S., Lefebvre, R. A., Colardyn, F., & Remon, J. P. (1993a). Influence of the application site on bioadhesion and slow-release characteristics of a bioadhesive buccal slow-release tablet of miconazole. European Journal of Clinical Pharmacology, 44, 331-335.
14. Bouckaert, S., Lefebvre, R. A., & Remon, J. P. (1993b). In vitro/in vivo correlation of the bioadhesive properties of a buccal bioadhesive miconazole slow-release tablet. Pharmaceutical Research, 10(6), 853-856.
15. Brook, I. M., Tucker, G. T., Tuckley, E. C., & Boyes, R. N. (1989). A lignocaine patch for dental analgesia safety and early pharmacology. Journal of Controlled Release, 10, 183-188.
16. Chidambaram, N., & Srivatsava, A. K. (1995). Buccal drug delivery systems. Drug Development and Industrial Pharmacy, 21(9), 1009-1036.
17. Choi, H.-G., & Kim, C.-K. (2000). Development of omeprazole buccal adhesive tablets with stability enhancement in human saliva. Journal of Controlled Release, 68, 397-404.
18. Choi, H.-G., Jung, J.-H., Yong, C. S., Rhee, C.-D., Lee, M.-K., Han, J.-H., Park, K.-M., & Kim, C.-K. (2000). Formulation and in vivo evaluation of omeprazole buccal adhesive tablet. Journal of Controlled Release, 68, 405-412.
19. Collins, A. E., & Deasy, P. B. (1990). Bioadhesive lozenge for the improved delivery of cetylpyridinium chloride. Journal of Pharmaceutical Sciences, 79, 116-119.
20. Cui, Z., & Mumper, R. J. (2002a). Bilayer films for mucosal (genetic) immunization via the buccal route in rabbits. Pharmaceutical Research, 19(7), 947-953.
21. Cui, Z., & Mumper, R. J. (2002b). Buccal transmucosal delivery of calcitonin in rabbits using thin-film composites. Pharmaceutical Research, 19(12), 1901-1906.
22. DeGrande, G., Benes, L., Horriére, F., Karsenty, H., Lacoste, C., McQuinn, R., Guo, J. H., & Scherrer, R. (1996). Specialized oral mucosal drug delivery systems: patches. In M. J. Rathbone (Ed.), Oral Mucosal Drug Delivery (pp. 285-317). New York: Marcel Dekker.
23. Dowty, M. E., Knuth, K. E., Irons, B. K., & Robinson, J. R. (1992). Transport of thyrotropin releasing hormone in rabbit buccal mucosa in vitro. Pharmaceutical Research, 9, 1113-1122.
24. Edgar, W. M. (1992). Saliva: its secretion, composition and functions. British Dental Journal, 172, 305-312.
25. Eouani, C., Piccerelle, Ph., Prinderre, P., Bourret, E., & Joachim, J. (2001). In vitro comparative study of buccal mucoadhesive performance of different polymeric films. European Journal of Pharmacy and Biopharmacy, 52, 45-55.
26. Friedman, M., & Golomb, G. (1982). New sustained release dosage form of chlorhexidine for dental use. Journal of Periodontal Research, 17, 323-328.
27. Gandhi, R. E., & Robinson, J. R. (1988). Bioadhesion in drug delivery. Indian Journal of Pharmaceutical Sciences, 50, 145-152.
28. Gandhi, R. E., & Robinson, J. R. (1994). Oral cavity as a site for bioadhesive drug delivery. Advanced Drug Delivery Reviews, 13, 43-74.
29. Garcia, A. L., Lara, E. H. G., & Panzeri, H. P. (1998). Estudo in vitro de sistemas bioadesivos para liberação sustentada de fluoreto. Revista de Odontologia da Universidade de São Paulo, 12(2), 143-148.
30. Glantz, P. O. J., Arnebrant, T., Nylander, T., & Baier, R. E. (1999). Bioadhesion - a phenomenon with multiple dimensions. Acta Odontologica Scandinavica, 57, 238-241.
31. Guo, J. H. (1994). Investigating the surface properties and bioadhesion of buccal patches. Journal of Pharmacy and Pharmacology, 46, 647-650.
32. Guo, J. H., & Cooklock, K. M. (1996). The effects of backing materials and multilayered systems on the characteristics of bioadhesive buccal patches. Journal of Pharmacy and Pharmacology, 48, 255-257.
33. Guo, J. H., & Cremer, K. (1999). Development of bioadhesive buccal patches. In: E. Mathiowitz, D. E. Chickering, & M. Lehr (Eds.), Bioadhesive Drug Delivery Systems (pp. 541-562). New York: Marcel Dekker.
34. Harris, D. H., & Robinson, J. R. (1992). Drug delivery via the mucous membranes of the oral cavity. Journal of Pharmaceutical Sciences, 81, 1-10.
35. Huang, Y., Leobandung, W., Foss, A., & Peppas, N. A. (2000). Molecular aspects of muco- and bioadhesion: tethered structures and site-specific surfaces. Journal of Controlled Release, 65, 41-63.
36. Ikinci, G., Senel, S., Akincibay, H., Kas, S., Ercis, S., Wilson, C. G., & Hincal, A. A. (2002). Effect of chitosan on a periodontal pathogen Porphyromonas gingivalis. International Journal of Pharmaceutics, 235, 121-127.
37. Jain, A. C., Aungust, B. J., & Adeyeye, M. C. (2002). Development and in vivo evaluation of buccal tablets prepared using danazolsulfobutylether 7 β-cyclodextrin (SBE) complexes. Journal of Pharmaceutical Sciences, 91(7), 1659-1668.
38. Jones, D. S., & Medlicott, N. J. (1995). Casting solvent controlled release of chlorhexidine from ethylcellulose films prepared by solvent evaporation. International Journal of Pharmaceutics, 114, 257-261.
39. Jones, D. S., Woolfson, A. D., Djokic, J., & Coulter, W. A. (1996). Development and mechanical characterization of bioadhesive semi-solid, polymeric systems containing tetracycline for the treatment of periodontal diseases. Pharmaceutical Research, 13(11), 1734-1738.
40. Jones, D. S., Woolfson, A. D., & Brown, A. F. (1997). Textural, viscoelastic and mucoadhesive properties of pharmaceutical gels composed of cellulose polymers. International Journal of Pharmaceutics, 151, 223-233.
41. Jones, D. S., Irwin, C. R., Woolfson, A. D., Djokic, J., & Adams, V. (1999). Physicochemical characterization and preliminary in vivo efficacy of bioadhesive, semisolid formulations containing flurbiprofen for the treatment of gingivitis. Journal of Pharmaceutical Sciences, 88(6), 592-598.
42. Jones, D. S., Woolfson, A. D., Brown, A. F., Coulter, W. A., Mcclelland, C., & Irwin, C. R. (2000). Design, characterisation and preliminary clinical evaluation of a novel mucoadhesive topical formulation containing tetracycline for the treatment of periodontal disease. Journal of Controlled Release, 67, 357-368.
43. Kashi, S. D., & Lee, V. H. L. (1986). Enkephalin hydrolysis in homogenates of various absorptive mucosa of the albino rabbit: similarities in rates and involvement of aminopeptidases. Life Sciences, 38, 2019-2028.
44. Kockisch, S., Rees, G. D., Young, S. A., Tsibouklis, J., & Smart, J. S. (2001). A direct-staining method to evaluate the mucoadhesion of polymers from aqueous dispersion. Journal of Controlled Release, 77, 1-6.
45. Kohda, Y., Kobayashi, H., Baba, Y., Yuasa, H., Ozeki, T., Kanaya, Y., & Sagara, E. (1997). Controlled release of lidocaine hydrochloride from buccal mucosa-adhesive films with solid dispersion. International Journal of Pharmaceutics, 158, 147-155.
46. Langoth, N., Kalbe, J., & Bernkop-Schnürch, A. (2003). Development of buccal drug delivery systems based on a thiolated polymer. International Journal of Pharmaceutics, 252, 141-148.
47. Lara, E. H. G., Garcia, A. L., & Panzeri, H. (1998). Estudos de sistemas acrílicos bioadesivos para liberação sustentada in vitro de fluoreto. Revista de Odontologia da Universidade de São Paulo, 12(3), 287-291.
48. Lee, V. H. L., & Yamamoto, A. (1990). Penetration and enzymatic barriers to peptide and protein absorption. Advanced Drug Delivery Reviews, 4, 171-207.
49. Lehr, C. M. (1996). From stick stuff to sweet receptors - achievements, limits and novel approaches to bioadhesion. European Journal of Drug Metabolism and Pharmacokinetics, 21(2), 139-148.
50. Li, C., Bhatt, P. P., & Johnston, T. P. (1998). Evaluation of a mucoadhesive buccal patch for delivery of peptides: in vitro screening of bioadhesion. Drug Development and Industrial Pharmacy, 24(10), 919-926.
51. Martin, L., Wilson, C. G., Koosha, F., & Uchegbu, I. F. (2003). Sustained buccal delivery of the hydrophobic drug denbufylline using physically cross-linked palmitoyl glycol chitosan hydrogels. European Journal of Pharmacy and Biopharmacy, 55, 35-45.
52. Matsuda, S., Iwata, H., Se, N., & Ikada, Y. (1999). Bioadhesion of gelatin films crosslinked with glutaraldehyde. Journal of Biomedical Materials Research, 45, 20-27.
53. McGinity, J. W., Zhang, F., Repka, M. A., & Koleng, J. J. (2001). Hot-melt extrusion as a pharmaceutical process. American Pharmaceutical Review, 4(2), 25-36.
54. Medlicott, N. J., Rathbone, M. J., Tucker, I. G., & Holborow, D. W. (1994). Delivery systems for the administration of drugs to the periodontal pocket. Advanced Drug Delivery Reviews, 13, 181-203.
55. Minabe, M., Tamura, T., Hori, T., & Umemoto, T. (1989). Subgingival administration of tetracycline on a collagen film. Journal of Periodontology, 60, 552-556.
56. Miyazaki, S., Kawasaki, N., Nakamura, T., Iwatsu, M., Hayashi, T., Hou, W.-M., & Attwood, D. (2000). Oral mucosal bioadhesive tablets of pectin and HPMC: in vitro and in vivo evaluation. International Journal of Pharmaceutics, 204, 127-132.
57. Nafee, N. A., Ismail, F. A., Boraie, N. A., & Mortada, L. M. (2003). Mucoadhesive buccal patches of miconazole nitrate: in vitro/in vivo performance and effect of ageing. International Journal of Pharmaceutics, 264, 1-14.
58. Nakada, Y., Awata, N., Nakamichi, C., & Sugimoto, I. (1987). Stability of human calcitonin in the supernatant of the rat's oral mucosa homogenate. Yakuz, 47, 217-223.
59. Needleman, I. G. (1991). Controlled drug release in periodontics: a review of new therapies. British Dental Journal, 170, 405-408.
60. Needleman, I. G., & Smales, F. C. (1995). In vitro assessment of bioadhesion for periodontal and buccal drug delivery. Biomaterials, 16, 617-624.
61. Newman, H. N. (1992). Chemical agents in the management of inflammatory periodontal diseases. In H. N. Newman & D. M. Williams (Eds.), Inflammation and Immunology in Chronic Inflammatory Periodontal Disease (pp. 141-167). Northwood: Science Reviews.
62. Park, C. R., & Munday, D. L. (2002). Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. International Journal of Pharmaceutics, 237, 215-226.
63. Park, H., & Robinson, J. R. (1984). Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion. International Journal of Pharmaceutics, 19, 107-127.
64. Patel, D., Smith, J. R., Smith, A. W., Grist, N., Barnett, P., & Smart, J. D. (2000). An atomic force microscopy investigation of bioadhesive polymer adsorption onto human buccal cells. International Journal of Pharmaceutics, 200, 271-277.
65. Peh, K. K., & Wong, C. F. (1999). Polymerics films as vehicle for buccal delivery: swelling, mechanical, and bioadhesive properties. Journal of Pharmacy and Pharmaceutical Sciences, 2(2), 53-61.
66. Peppas, N. A., & Sahlin, J. (1996). Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials, 17, 1553-1561.
67. Rathbone, M. J., & Tucker, I. G. (1993). Mechanisms, barriers and pathways of oral mucosal drug permeation. Advanced Drug Delivery Reviews, 12, 41-60.
68. Repka, M. A., & McGinity, J. W. (2000a). Physical-mechanical, moisture absorption and bioadhesive properties of hydroxypropylcellulose hot-melt extruded films. Biomaterials, 21(14), 1509-1517.
69. Repka, M. A., & McGinity, J. W. (2000b). Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. International Journal of Pharmaceutics, 202(1-2), 63-70.
70. Repka, M. A., & McGinity, J. W. (2001a). Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. Journal of Controlled Release, 70, 341-351.
71. Repka, M. A., & McGinity, J. W. (2001b). Influence of chlorpheniramine maleate on topical films produced by hot-melt extrusion. Pharmaceutical Development and Technology, 6(3), 295-302.
72. Repka, M. A., Gerding, T. G., Repka, S. L., & McGinity, J. W. (1999). Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot-melt extrusion. Drug Development and Industrial Pharmacy, 25(5), 625-633.
73. Repka, M. A., Prodduturi, S., & Stodghill, S. P. (2003). Production and characterization of hot-melt extruded films containing clotrimazole. Drug Development and Industrial Pharmacy, 29(7), 757-765.
74. Repka, M. A., Prodduturi, S., Munjai, M., & Mididoddi, P. (2004). Matrix and reservoir-based transmucosal delivery systems: tailoring delivery solutions. American Journal of Drug Delivery, 2(3), 173-192.
75. Rossi, S., Sandri, G., Ferrari, F., Bonferoni, M. C., & Caramella, C. (2003). Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid. Pharmaceutical Development and Technology, 8(2), 199-208.
76. Schmidgall, J., Schnetz, E., & Hensel, A. (2000). Evidence for bioadhesive effects of polysaccharides and polysaccharide-containing herbs in an ex vivo bioadhesion assay on buccal membranes. Planta Medica, 66, 48-53.
77. Senel, S., Kremer, M. J., Kas, S., Wertz, P. W., Hincal, A. A., & Squier, C. A. (2000). Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials, 21, 2067-2071.
78. Shin, S. C., Bum, J. P., & Choi, J. S. (2000). Enhanced bioavailability by buccal administration of triamcinolone acetonide from the bioadhesive gels in rabbits. International Journal of Pharmaceutics, 209, 37-43.
79. Shojaei, A. H. (1998). Buccal mucosa as a route for systemic drug delivery: a review. Journal of Pharmacy and Pharmaceutical Sciences, 1(1), 15-30.
80. Shojaei, A. H., Paulson, J., & Honary, S. (2000). Evaluation of poly(acrylic acid-co-ethylhexyl acrylate) films for mucoadhesive transbuccal drug delivery: factors affecting the force of mucoadhesion. Journal of Controlled Release, 67, 223-232.
81. Singh, B., & Ahuja, N. (2002). Development of controlled-release buccoadhesive hydrophilic matrices of diltiazem hydrochloride: optimization of bioadhesion, dissolution, and diffusion parameters. Drug Development and Industrial Pharmacy, 28(4), 432-442.
82. Song, I. S., Yoshioka, M., Erickson, R. H., Miura, S., Guan, D., & Kim, Y. S. (1986). Identification and characterization of brush-border membrane-bound neutral metalloendopeptidases from rat small intestine. Gastroenterology, 91, 1234-1242.
83. Soskolone, W. A., & Freidman, M. F. (1996). Intra-periodontal pocket drug delivery systems. Oral Mucosal Drug Delivery. New York: Marcel Dekker, 359-379.
84. Steinberg, D. A., Friedman, M., Soskolne, A., & Sela, M. N. (1990). A new degradable controlled release device for treatment of periodontal disease: in vitro release study. Journal of Periodontology, 61(7), 393-398.
85. Stephenson, S. L., & Kenny, A. J. (1988). The metabolism of neuropeptides. Hydrolysis of peptides by the phosphoramidon-insensitive rat kidney enzyme 'endopeptidase-2' and rat microvillar membranes. Biochemical Journal, 255, 45-51.
86. Tiwari, D., Sause, R., & Madan, P. L. (1999a). Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci, 1(3), 1-7.
87. Tiwari, D., Goldman, D., Town, C., Sause, R., & Madan, P. L. (1999b). In vitro-in vivo evaluation of a controlled release buccal bioadhesive device for oral drug delivery. Pharmaceutical Research, 16(11), 1775-1780.
88. Tsutsumi, K., Obata, Y., Nagai, T., Loftsson, T., & Takayama, K. (2002). Buccal absorption of ergotamine tartrate using the bioadhesive tablet system in guinea-pigs. International Journal of Pharmaceutics, 238, 161-170.
89. Varshosaz, J., & Dehghan, Z. (2002). Development and characterization of buccoadhesive nifedipine tablets. European Journal of Pharmacy and Biopharmacy, 54, 135-141.
90. Vinholis, A. H. C., Figueiredo, L. C., Jr., Marcantonio, E., Marcantonio, R. A. C., Salvador, S. L. S., & Goissis, G. (2001). Subgingival utilization of a 1% chlorhexidine collagen gel for the treatment of periodontal pockets. A clinical and microbiological study. Brazilian Dental Journal, 12(3), 209-213.
91. Vivien-Castioni, N., Gurny, R., Baehni, P., & Kaltsatos, V. (2000). Salivary fluoride concentrations following applications of bioadhesive tablets and mouth rinses. European Journal of Pharmacy and Biopharmacy, 49, 27-33.
92. Voorspoels, J., Remon, J. P., Eechaute, W., & De Sy, W. (1996). Buccal absorption of testosterone and its esters using a bioadhesive tablet in dogs. Pharmaceutical Research, 13(8), 1228-1232.
93. Walker, G. F., Langoth, N., & Bernkop-Schnürch, A. (2002). Peptidase activity on the surface of the porcine buccal mucosa. International Journal of Pharmaceutics, 233, 141-147.
94. Walton, A. G., & Rutland, R. F. (1998). Glyceryl trinitrate preparation (Suscard Buccal) causes caries and changes to the denture base material. British Dental Journal, 185(6), 288-289.
95. Wong, C. F., Yuen, K. H., & Peh, K. K. (1999a). Formulation and evaluation of controlled release Eudragit buccal patches. International Journal of Pharmaceutics, 178, 11-22.
96. Wong, C. F., Yuen, K. H., & Peh, K. K. (1999b). An in-vitro method for buccal adhesion studies: importance of instrument variables. International Journal of Pharmaceutics, 180, 47-57.
97. Woodley, J. (2001). Bioadhesion: new possibilities for drug administration? Clinical Pharmacokinetics, 40(2), 77-84.
98. Yamamoto, A., Hayakawa, E., & Lee, V. H. L. (1990). Insulin and proinsulin in mucosal homogenates of the albino rabbit: implications in peptide delivery from normal routes. Life Sciences, 47, 2465-2474.
99. Zhang, H., & Robinson, J. R. (1996). Routes of drug transport across oral mucosa. In M. Rathbone (Ed.), Oral Mucosal Drug Delivery (pp. 51-63). New York: Marcel Dekker.